Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRicardo Plc Regulatory News (RCDO)

  • This share is currently suspended. It was suspended at a price of 430.00
  • There is currently no data for RCDO

Director/PDMR Shareholding

16 Oct 2013 16:25

RNS Number : 6917Q
Ricardo PLC
16 October 2013
 



Ricardo PLC

 

Director / PDMR Shareholdings

 

16 October 2013

London

 

1. 2006 Long Term Incentive Plan - grant of plan cycle 7

 

Ricardo PLC (the "Company") announces that, on 16 October 2013, conditional awards over a total of 185,399 shares of 25 pence each in the Company ("Shares") were granted to Executive Directors and other PDMRs under the terms of the Company's 2006 Long Term Incentive Plan (the "LTIP"), as set out below. These awards vest after three years and are subject to TSR and EPS performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

73,380

Ian Gibson

Executive Director

25,983

Mark Garrett

Executive Director

22,676

Martin Fausset

PDMR

14,430

Tom Apostolos

PDMR

9,423

Robert Hentschel

PDMR

8,615

Markus Döerr

PDMR

12,674

Gary Tan

PDMR

9,199

Robert Bell

PDMR

9,019

 

2. 2011 Deferred Bonus Plan - grant of deferred awards and matching awards

 

The Company also announces that, on 16 October 2013, conditional "deferred awards" over a total of 62,931 Shares were granted to Executive Directors and other PDMRs under the terms of the Company's 2011 Deferred Bonus Plan ("DBP"), as set out below. Subject to continuing employment, these awards vest after three years. These DBP deferred awards (which include dividend equivalent entitlements) are not subject to performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

34,292

Mark Garrett

Executive Director

15,620

Martin Fausset

PDMR

5,848

Tom Apostolos

PDMR

3,817

Gary Tan

PDMR

3,354

 

Finally, further conditional "matching awards" over a total of 49,912 Shares were granted to Executive Directors under the terms of the DBP on the basis of one Share comprised in such a "matching award" for each Share comprised in the corresponding deferred award (detailed above) granted to an individual on the same occasion. Details of these DBP matching awards, which do not include dividend equivalent entitlements, but are subject to the same performance conditions that apply to the awards granted on 16 October 2013 under cycle 7 of the LTIP, are set out below:

 

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

34,292

Mark Garrett

Executive Director

15,620

 

 

3. Current total holdings of awards / options over Shares

 

Following the above notifications, the total number of Shares over which the relevant Executive Directors and other PDMRs hold outstanding awards / options is set out below:

 

 Name

Role

Total no. of Shares subject to awards and options now held

Approximate % of Company's issued share capital

Dave Shemmans

Executive Director

616,044

1.18%

Ian Gibson

Executive Director

25,983

0.05%

Mark Garrett

Executive Director

221,144

0.42%

Martin Fausset

PDMR

71,753

0.14%

Tom Apostolos

PDMR

36,699

0.07%

Robert Hentschel

PDMR

8,615

0.02%

Markus Döerr

PDMR

99,208

0.19%

Gary Tan

PDMR

29,972

0.06%

Robert Bell

PDMR

23,554

0.05%

 

The above notifications are intended to satisfy the Company's obligations under Disclosure and Transparency Rule ("DTR") 3.1.4R.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZMMMGKVDGFZM
Date   Source Headline
1st Feb 20247:00 amRNSTrading Update
22nd Jan 20249:51 amRNSDirector/PDMR Shareholding
15th Jan 20249:57 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSDirector/PDMR Shareholding
18th Dec 202310:00 amRNSDirector/PDMR Shareholding
18th Dec 20239:00 amRNSDirector/PDMR Shareholding
28th Nov 20233:53 pmRNSDirector/PDMR Shareholding
27th Nov 20235:45 pmRNSDirector/PDMR Shareholding
20th Nov 202310:31 amRNSDirector/PDMR Shareholding
17th Nov 20237:00 amRNSResult of AGM
14th Nov 20237:00 amRNSDirector/PDMR Shareholding
9th Nov 20239:29 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
13th Oct 20239:08 amRNSNotice of AGM
10th Oct 20239:10 amRNSDirector/PDMR Shareholding
28th Sep 20239:36 amRNSHolding(s) in Company
28th Sep 20239:36 amRNSHolding(s) in Company
18th Sep 20235:37 pmRNSDirector/PDMR Shareholding
14th Sep 20239:17 amRNSDirector/PDMR Shareholding
13th Sep 20237:01 amRNSPreliminary Results
13th Sep 20237:00 amRNSConfirmation of CFO Change and Board Appointment
12th Sep 20239:00 amRNSBlock listing Interim Review
7th Aug 20237:43 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSTrading Update
25th Jul 20237:49 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSJudith Cottrell joins Ricardo and the Board
16th Jun 20233:43 pmRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSHolding(s) in Company
24th May 20237:00 amRNSCapital Markets Day
15th May 20238:37 amRNSDirector/PDMR Shareholding
26th Apr 20237:00 amRNSCapital Markets Day
17th Apr 20233:48 pmRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSAppointment of Chief Financial Officer
14th Mar 20235:08 pmRNSDirector/PDMR Shareholding
13th Mar 20234:12 pmRNSBlock listing Interim Review
13th Mar 20234:11 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNSAcquisition of Aither Pty Ltd.
1st Mar 20237:00 amRNSInterim Results
17th Feb 202311:00 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTrading Update
25th Jan 20237:00 amRNSRicardo Completes Acquisition
13th Jan 20233:02 pmRNSDirector/PDMR Shareholding
11th Jan 202312:31 pmRNSHolding(s) in Company
21st Dec 202212:48 pmRNSDirector/PDMR Shareholding
21st Dec 202212:44 pmRNSDirector/PDMR Shareholding
2nd Dec 20221:57 pmRNSDirector/PDMR Shareholding
17th Nov 202211:07 amRNSResult of AGM
11th Nov 20224:18 pmRNSDirector/PDMR Shareholding
25th Oct 20221:12 pmRNSDirector/PDMR Shareholding
11th Oct 20223:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.